Cargando…
coreNASH: Multi‐stakeholder Consensus on Core Outcomes for Decision Making About Nonalcoholic Steatohepatitis Treatment
The increasing prevalence and burden of nonalcoholic steatohepatitis (NASH) has spurred the development of new treatments and a need to consider outcomes used for NASH treatment decision making. Development of a NASH core outcome set (COS) can help prioritize outcomes of highest importance by incorp...
Autores principales: | Clearfield, Elizabeth, Miller, Veronica, Nadglowski, Joseph, Barradas, Katherine, Al Naber, Jennifer, Sanyal, Arun J., Neuschwander‐Tetri, Brent A., Messner, Donna A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122373/ https://www.ncbi.nlm.nih.gov/pubmed/34027268 http://dx.doi.org/10.1002/hep4.1678 |
Ejemplares similares
-
The metabolic basis of nonalcoholic steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020) -
Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis
por: Twiss, James, et al.
Publicado: (2023) -
An Inhibitor of Arginine‐Glycine‐Aspartate‐Binding Integrins Reverses Fibrosis in a Mouse Model of Nonalcoholic Steatohepatitis
por: Ulmasov, Barbara, et al.
Publicado: (2018) -
coreSCD: multi-stakeholder consensus on core outcomes for sickle cell disease clinical trials
por: Tambor, Ellen, et al.
Publicado: (2021) -
The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic Steatohepatitis
por: Sanyal, Arun, et al.
Publicado: (2023)